Last Scientist in Congress has Human Genetic Engineering Warning
By Bill Foster,
The Hill
| 07. 08. 2015
It is rare that prominent members of the scientific community come together to warn our leaders of technological breakthroughs that our legal system and society are not prepared for. As the last scientist with a Ph.D. remaining in Congress, I feel a responsibility to transmit those concerns to my colleagues and to the public.
The breakthrough in question relates to human genetic engineering. This has long been a theoretical possibility assumed to be decades away from practicality. In the last several years this has changed significantly due to recent breakthroughs that allow inexpensive and precise editing of chromosomal DNA. The technological potential has been amplified by the widespread adoption of in vitro fertilization, the rapid decline in the cost of genome sequencing, increasing use of Big Data to understand the relationship between genetic variations and behavior and the rapid spread of these technologies throughout the world.
It's time for leaders in government to take notice.
The ability to modify DNA has been around for decades, but until recently it was expensive and time consuming, and required a very high level...
Related Articles
By Nicholas Wade, The New York Times | 04.30.2026
“J. Craig Venter” via Wikimedia Commons licensed under CC by 2.5
J. Craig Venter, a scientist and entrepreneur who raced to decode the human genome, died on Wednesday in San Diego. He was 79.
His death was announced by...
By Susan Dominus, The New York Times Magazine | 04.27.2026
Why are babies born young? The most natural phenomenon on earth is actually hard to explain — at least on a cellular level. Consider this problem: The components of conception are old. When a woman gets pregnant, she has...
By Jonathan Basile, Los Ángeles Review of Books | 04.29.2026
WILLIAM BATESON, a foundational figure in the science of genetics at the turn of the last century, once recounted the response of a Scottish soldier to one of his public lectures: “Sir, what ye’re telling us is nothing but Scientific...
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...